Prevention and control of cystic echinococcosis

被引:453
作者
Craig, Philip S.
McManus, Donald P.
Lightowlers, Marshall W.
Chabalgoity, Jose A.
Garcia, Hector H.
Gavidia, Cesar M.
Gilman, Robert H.
Gonzalez, Armando E.
Lorca, Myriarn
Naguira, Cesar
Nieto, Alberto
Schantz, Peter M.
机构
[1] Inst Ciencias Neurol Jr Ancash, Cysticercosis Unit, Lima 1, Peru
[2] Univ Salford, Sch Environm & Life Sci, Cestode Zoonoses Res Grp, Salford M5 4WT, Lancs, England
[3] Queensland Inst Med Res, Brisbane, Qld 4006, Australia
[4] Univ Melbourne, Melbourne, Vic, Australia
[5] Univ Republica, Dept Biotechnol, Inst Higiene, Montevideo, Uruguay
[6] Univ Republica, Catedra Inmunol, Sch Chem, Montevideo, Uruguay
[7] Univ Peruana Cayetano Heredia, Dept Microbiol, Lima, Peru
[8] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[9] Univ Nacl Mayor San Marcos, Sch Vet Med, Lima 14, Peru
[10] Univ Chile, Santiago, Chile
[11] Minist Salud, Inst Nacl Salud, Lima, Peru
[12] Ctr Dis Control & Prevent, Div Parasit Dis, Atlanta, GA USA
基金
英国惠康基金;
关键词
D O I
10.1016/S1473-3099(07)70134-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Human cystic echinococcosis (hydatid disease) continues to be a substantial cause of morbidity and mortality in many parts of the world. Elimination is difficult to obtain and it is estimated that, using current control options, achieving such a goal will take around 20 years of sustained efforts. Since the introduction of current (and past) hydatid control campaigns, there have been clear technological improvements made in the diagnosis and treatment of human and animal cystic echinococcosis, the diagnosis of canine echinococcosis, and the genetic characterisation of strains and vaccination against Echinococcus granulosus in animals. Incorporation of these new measures could increase the efficiency of hydatid control programmes, potentially reducing the time required to achieve effective prevention of disease transmission to as little as 5-10 years.
引用
收藏
页码:385 / 394
页数:10
相关论文
共 127 条
[1]   Copro-diagnosis of Echinococcus granulosus infection in dogs by amplification of a newly identified repeated DNA sequence [J].
Abrasi, I ;
Branzburg, A ;
Campos-Ponce, M ;
Hafez, SKA ;
Raoul, F ;
Craig, PS ;
Hamburger, J .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2003, 69 (03) :324-330
[2]   Past to present: echinococcosis in Turkey [J].
Altintas, N .
ACTA TROPICA, 2003, 85 (02) :105-112
[3]  
ANDERSEN FL, 1994, P ANN M US ANIM HLTH, V78, P37
[4]  
Ayles HM, 2002, ANN ROY COLL SURG, V84, P100
[5]   ANTIBODY-RESPONSES TO INVITRO TRANSLATION PRODUCTS FOLLOWING ALBENDAZOLE THERAPY FOR ECHINOCOCCUS-GRANULOSUS [J].
BLANTON, RE ;
OKELO, GBA ;
KIJOBE, J ;
KING, CH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (08) :1674-1676
[6]   Oxfendazole treatment for cystic hydatid disease in naturally infected animals [J].
Blanton, RE ;
Wachira, TM ;
Zeyhle, EE ;
Njoroge, EM ;
Magambo, JK ;
Schantz, PM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) :601-605
[7]  
Budke CM, 2006, EMERG INFECT DIS, V12, P296
[8]   Economic effects of echinococcosis in a disease-endemic region of the Tibetan plateau [J].
Budke, CM ;
Qiu, JM ;
Wang, Q ;
Torgerson, PR .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (01) :2-10
[9]   Control of Echinococcus granulosus in Uruguay:: evaluation of different treatment intervals for dogs [J].
Cabrera, PA ;
Lloyd, S ;
Haran, G ;
Pineyro, L ;
Parietti, S ;
Gemmell, MA ;
Correa, O ;
Morana, A ;
Valledor, S .
VETERINARY PARASITOLOGY, 2002, 103 (04) :333-340
[10]   Rates of reinfection with Echinococcus granulosus, Taenia hydatigena, Taenia ovis and other cestodes in a rural dog population in Uruguay [J].
Cabrera, PA ;
Parietti, S ;
Haran, G ;
Benavidez, U ;
Lloyd, S ;
Perera, G ;
Valledor, S ;
Gemmell, MA ;
Botto, T .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1996, 26 (01) :79-83